X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6104) 6104
Publication (1013) 1013
Book Review (64) 64
Book Chapter (43) 43
Dissertation (26) 26
Conference Proceeding (15) 15
Book / eBook (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3848) 3848
humans (3807) 3807
kras (3794) 3794
oncology (2813) 2813
mutation (2812) 2812
female (2099) 2099
male (1895) 1895
cancer (1843) 1843
colorectal cancer (1673) 1673
middle aged (1657) 1657
aged (1543) 1543
ras proteins - genetics (1207) 1207
adult (1185) 1185
genetic aspects (1124) 1124
colorectal neoplasms - genetics (1079) 1079
proto-oncogene proteins - genetics (1057) 1057
proto-oncogene proteins p21 (1040) 1040
chemotherapy (1023) 1023
tumors (1008) 1008
braf (1007) 1007
cetuximab (964) 964
egfr (958) 958
kras mutations (956) 956
prognosis (949) 949
aged, 80 and over (878) 878
pathology (873) 873
metastasis (821) 821
colorectal neoplasms - pathology (815) 815
proto-oncogene proteins p21 - genetics (799) 799
adenocarcinoma (789) 789
lung neoplasms - genetics (788) 788
proto-oncogene proteins b-raf - genetics (727) 727
animals (720) 720
analysis (711) 711
gene mutations (691) 691
mutations (686) 686
survival (686) 686
expression (672) 672
lung cancer (664) 664
research (662) 662
digestive system diseases (649) 649
neoplasms (630) 630
kras mutation (612) 612
cell biology (609) 609
colorectal neoplasms - drug therapy (607) 607
care and treatment (603) 603
article (593) 593
growth-factor receptor (590) 590
adenocarcinoma - genetics (570) 570
biomarkers, tumor - genetics (536) 536
dna mutational analysis (535) 535
cell line, tumor (518) 518
therapy (511) 511
k-ras (510) 510
microsatellite instability (507) 507
lung neoplasms - pathology (501) 501
carcinoma (496) 496
1st-line treatment (475) 475
mice (473) 473
receptor, epidermal growth factor - genetics (467) 467
pancreatic cancer (459) 459
carcinoma, non-small-cell lung - genetics (458) 458
mutation - genetics (430) 430
neoplasm staging (425) 425
antineoplastic agents - therapeutic use (422) 422
gefitinib (422) 422
immunohistochemistry (421) 421
colorectal-cancer (415) 415
health aspects (415) 415
panitumumab (415) 415
genes (412) 412
colon-cancer (401) 401
patients (397) 397
epidermal growth factor (396) 396
retrospective studies (394) 394
kinases (393) 393
deoxyribonucleic acid--dna (388) 388
treatment outcome (384) 384
cancer therapies (375) 375
signal transduction (375) 375
adenocarcinoma - pathology (370) 370
polymerase chain reaction (366) 366
surgery (360) 360
gene (357) 357
cell lung-cancer (355) 355
proteins (351) 351
biomarkers (347) 347
development and progression (345) 345
biochemistry & molecular biology (344) 344
receptor, epidermal growth factor - antagonists & inhibitors (337) 337
antineoplastic combined chemotherapy protocols - therapeutic use (335) 335
ras (335) 335
k-ras mutations (334) 334
disease-free survival (333) 333
resistance (331) 331
gene expression (329) 329
genes, ras (324) 324
activation (320) 320
medical prognosis (319) 319
acquired-resistance (318) 318
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5982) 5982
French (70) 70
German (23) 23
Chinese (21) 21
Spanish (20) 20
Russian (13) 13
Japanese (7) 7
Korean (7) 7
Polish (5) 5
Czech (3) 3
Persian (2) 2
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 06/2011, Volume 6, Issue 6, pp. 1006 - 1015
Journal Article
Cancer Discovery, ISSN 2159-8274, 07/2018, Volume 8, Issue 7, pp. 822 - 835
KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct... 
CTLA-4 BLOCKADE | CANCER-PATIENTS | MELANOMA | ONCOLOGY | COOCCURRING GENOMIC ALTERATIONS | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | NIVOLUMAB | LKB1 LOSS | DOCETAXEL | TUMOR MICROENVIRONMENT | non-small cell lung cancer | PD-1 blockade | STK11 | KRAS | LKB1 | lung adenocarcinoma
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2014, Volume 41, Issue 11, pp. 2058 - 2065
Journal Article
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 7/2011, Volume 122, Issue 1, pp. 11 - 19
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2014, Volume 38, Issue 9, pp. 1235 - 1241
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 85, Issue 1, pp. 19 - 24
Abstract Aim Non-small cell lung cancer (NSCLC)-patients with an epidermal growth factor receptor ( EGFR )-mutation have median progression-free survival (PFS)... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | EGFR mutation | T790M-mutation | NSCLC | Targeted therapy | Rebiopsy | TKI-resistance | TRANSFORMATION | NONSMALL CELL | GEFITINIB | MECHANISM | ADENOCARCINOMA | ACQUIRED-RESISTANCE | DRUG-RESISTANCE | CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | ONCOLOGY | RESPIRATORY SYSTEM | KRAS | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Mutation, Missense | Molecular Targeted Therapy | Incidence | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Retrospective Studies | Lung Neoplasms - genetics | Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - diagnosis | Biopsy | Protein Kinase Inhibitors - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Adenocarcinoma - mortality | Lung cancer, Non-small cell | Genetic aspects
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 05/2017, Volume 16, Issue 5, pp. 793 - 804
Journal Article